Comparison between Clinitech Laboratory IPO and V.L.Infraprojects IPO.
Clinitech Laboratory IPO is a SME Bookbuilding IPO proposed to list at BSE SME while V.L.Infraprojects IPO is a SME Bookbuilding proposed to list at NSE SME.
| Clinitech Laboratory IPO | V.L.Infraprojects IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Inventure Merchant Banker Services Pvt.Ltd. | Beeline Capital Advisors Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | Svcm Securities Pvt.Ltd. | Spread X Securities Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Clinitech Laboratory IPO is up to ₹5.48 Cr whereas the issue size of the V.L.Infraprojects IPO is up to ₹17.51 Cr. The final issue price of Clinitech Laboratory IPO is ₹96.00 per share and of V.L.Infraprojects IPO is ₹42.00 per share.
| Clinitech Laboratory IPO | V.L.Infraprojects IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹39.00 per share | |
| Issue Price (Upper) | ₹42.00 per share | |
| Issue Price (Final) | ₹96.00 per share | ₹42.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1200 shares | 3000 shares |
| Fresh Issue Size | 5,71,200 shares | 41,70,000 shares |
| Fresh Issue Size (Amount) | up to ₹5.48 Cr | up to ₹17.51 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 5,71,200 shares | 41,70,000 shares |
| Issue Size Total (Amount) | up to ₹5.48 Cr | up to ₹17.51 Cr |
Clinitech Laboratory IPO opens on Jul 25, 2024, while V.L.Infraprojects IPO opens on Jul 23, 2024. The closing date of Clinitech Laboratory IPO and V.L.Infraprojects IPO is Jul 29, 2024, and Jul 25, 2024, respectively.
| Clinitech Laboratory IPO | V.L.Infraprojects IPO | |
|---|---|---|
| Anchor Bid Date | Jul 22, 2024 | |
| Issue Open | Jul 25, 2024 | Jul 23, 2024 |
| Issue Close | Jul 29, 2024 | Jul 25, 2024 |
| Basis Of Allotment (Tentative) | Jul 30, 2024 | Jul 26, 2024 |
| Initiation of Refunds (Tentative) | Jul 31, 2024 | Jul 29, 2024 |
| Credit of Share (Tentative) | Jul 31, 2024 | Jul 29, 2024 |
| Listing date (Tentative) | Aug 01, 2024 | Jul 30, 2024 |
| Anchor Lockin End date 1 | Aug 25, 2024 | |
| Anchor Lockin End date 2 | Oct 24, 2024 |
Clinitech Laboratory IPO P/E ratio is 43.45, as compared to V.L.Infraprojects IPO P/E ratio of 7.73.
| Clinitech Laboratory IPO | V.L.Infraprojects IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 83.65 | 90.91 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 61.57 | 65.39 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 43.45 | 7.73 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹21.91 Cr. | ₹65.99 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 46.20% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 39.09% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.24 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹2.21 | ₹5.43 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 10.46% | 37.53% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Clinitech Laboratory IPO Retail Individual Investors (RII) are offered 2,85,600 shares while in V.L.Infraprojects IPO retail investors are offered 2,85,600 shares. Qualified Institutional Buyers (QIB) are offered in Clinitech Laboratory IPO and 8,34,000 shares in V.L.Infraprojects IPO.
| Clinitech Laboratory IPO | V.L.Infraprojects IPO | |
|---|---|---|
| Anchor Investor Reservation | 12,48,000 shares | |
| Market Maker Reservation | 31,200 shares | 2,40,000 shares |
| QIB | 8,34,000 shares | |
| NII | 2,85,600 shares | 6,27,000 shares |
| RII | 2,85,600 shares | 14,61,000 shares |
| Employee | ||
| Others | ||
| Total | 5,71,200 shares | 41,70,000 shares |
Clinitech Laboratory IPO subscribed 38.96x in total, whereas V.L.Infraprojects IPO subscribed 636.17x.
| Clinitech Laboratory IPO | V.L.Infraprojects IPO | |
|---|---|---|
| QIB (times) | 203.73x | |
| NII (times) | 23.28x | 726.56x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 49.61x | 844.22x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 38.96x | 636.17x |
